slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 55,141-55,170
Pages 2,605
Rows per page 30
Component
55,141-55,170 of 78,138
11
The slide uses a two-row layout to contrast 'Automotive' vs 'Other Markets' with specific TAM growth figures.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
16
The slide uses a three-column layout to detail specific software performance metrics.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank Beat · Solution1 hit
22
The slide uses a matrix-like structure to categorize partners by industry and stage of engagement.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank 1 hit
23
The slide uses a Gantt-style chart to show overlapping development and production phases for different product iterations (A, B, C, D).Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank 1 hit
31
Includes footnotes regarding transaction assumptions and capital structure.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank 1 hit
34
The chart uses a bubble plot to visualize valuation multiples (y-axis) vs growth (x-axis) for peers in the autonomous vehicle and computing space.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank 1 hit
35
Uses a DCF-style methodology to discount future enterprise value back to current value for comparison.Aeva | SPAC Presentation Deck | 36 slides · Aeva
Pitch deck Investment bank 1 hit
10
The slide highlights a 21% CAGR over the period. The growth drivers are categorized into New Products/Capabilities, Strategic Initiatives, and Acquisitions.Apollo Global Management | Investor Presentation Deck | 29 slides · Apollo Global Management
Pitch deck Investor relations Loop · Voice Of Customer1 hit
11
The diagram illustrates a hub-and-spoke model centered on Apollo, connecting various insurance entities.Apollo Global Management | Investor Presentation Deck | 29 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
14
The slide uses a clear visual distinction (green vs blue) to highlight the firm's performance against industry benchmarks.Apollo Global Management | Investor Presentation Deck | 29 slides · Apollo Global Management
Pitch deck Investor relations 1 hit
12
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
15
The slide uses a staircase diagram to represent dose escalation and a list for expansion cohorts.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
17
The chart uses a broken axis between 50 and 100.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
19
Waterfall plot showing clinical trial efficacy data.BioNTech | Results Presentation Deck | 25 slides · BioNTech
Deck Investor relations Beat · Solution1 hit
03
The chart uses a V-shape to illustrate the recovery from a low point in 1Q21.Capri Holdings | Results Presentation Deck | 9 slides · Capri Holdings
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
05
The slide uses a bubble chart to illustrate market growth from 2019 to 2025.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Problem Identification1 hit
12
The slide uses a two-column layout: left side details the value proposition/workflow, right side shows quantitative adoption metrics.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
14
Clover Health | Investor Day Presentation Deck | 47 slidesClover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
17
MCR = Medical Cost Ratio. The slide highlights a 1,100 basis point differential in Q1 2020.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations Beat · Solution1 hit
18
The chart illustrates how Clover Assistant (CA) reduces MCR through revenue and medical expense differentials.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
20
The chart uses a 2x2 matrix style to show competitive positioning.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
23
The slide uses a grouped bar chart to demonstrate competitive positioning over time.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
39
The chart illustrates the reconciliation of Medical Cost Ratio (MCR) adjustments.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
41
The chart uses a waterfall bridge format to explain the delta between 2019 MCR and projected 2023 MCR scenarios.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
42
The slide presents a standard SPAC transaction capital structure breakdown.Clover Health | Investor Day Presentation Deck | 47 slides · Clover Health
Conference presentation Investor relations 1 hit
07
The slide highlights technical capabilities and productivity metrics at the bottom.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
09
The slide shows a workflow from a 'toolbox of validated leads' to 'high-throughput expression & characterization' and finally to specific multi-specific constructs.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
15
The slide uses a series of line charts to demonstrate efficacy across different antibody affinities.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
19
The slide includes a Kaplan-Meier plot showing PFS outcomes for different patient cohorts (PD-1 refractory, immune competent).Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Beat · SolutionLoop · Golden Circle1 hit
35
The slide shows dose-response curves for specific lysis of tumor cells, highlighting the potency of NKp30-based bispecifics.Compass Therapeutics | IPO Presentation Deck | 40 slides · Compass Therapeutics
Pitch deck Investment bank Loop · Golden Circle1 hit